<p><strong>Chronic Kidney Disease Stages 3 And 4</strong>: Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with Chronic Kidney Disease (CKD) Stages 3 and 4.<br />
<br />
<strong>Chronic Kidney Disease Stage 5</strong>: Paricalcitol capsules are indicated in adults and pediatric patients 10 years of age and older for the prevention and treatment of secondary hyperparathyroidism associated with CKD Stage 5 in patients on hemodialysis&nbsp;(HD) or&nbsp;peritoneal dialysis&nbsp;(PD).</p>